Israel; Alain

Patent Applications and Registrations

Patent applications and USPTO patent grants for Israel; Alain.The latest application filed is for "optineurin-derived polypeptides, their nucleic acids and uses thereof".

Company Profile

0.6.11

Israel; Alain - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Optineurin-derived Polypeptides, Their Nucleic Acids And Uses Thereof App 20140336126 - Weil; Robert Serge ; et al.	2014-11-13
Methods of identifying NF-.kappa.B inhibitors Grant 8,790,883 - Agou , et al. July 29, 2	2014-07-29
Nucleotide Sequence Encoding A Modulator Of Nf-kb App 20110182811 - YAMAOKA; Shoji ; et al.	2011-07-28
Method For Screening For Selective Modulator Of The Nf-kb Pathway Activation App 20100240040 - Agou; Fabrice ; et al.	2010-09-23
Nucleotide Sequence Encoding A Modulator Of Nf-kb App 20100144615 - Yamaoka; Shoji ; et al.	2010-06-10
Selective inhibition of NF-.kappa.B activation by peptides designed to disrupt nemo oligomerization Grant 7,700,553 - Agou , et al. April 20, 2	2010-04-20
Nucleotide Sequence Encoding A Modulator Of Nf-kb App 20090061480 - Yamaoka; Shoji ; et al.	2009-03-05
Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization App 20080242601 - Agou; Fabrice ; et al.	2008-10-02
SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION App 20080207517 - AGOU; Fabrice ; et al.	2008-08-28
NF-.kappa.B peptides designed to disrupt NEMO oligomerization Grant 7,390,872 - Agou , et al. June 24, 2	2008-06-24
Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization App 20050220792 - Agou, Fabrice ; et al.	2005-10-06
Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-.kappa.B) activation Grant 6,824,972 - Kenwrick , et al. November 30, 2	2004-11-30
Nucleotide sequence encoding a modulator of NF-.kappa.B Grant 6,680,366 - Yamaoka , et al. January 20, 2	2004-01-20
Nucleotide sequence encoding a modulator of NF-kappaB App 20030228667 - Yamaoka, Shoji ; et al.	2003-12-11
Nucleotide sequence encoding a modulator of NF-kappaB App 20030059911 - Yamaoka, Shoji ; et al.	2003-03-27
Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-kappaB) activation App 20030032055 - Kenwrick, Sue J. ; et al.	2003-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.